Lopixibat is a selective guanylate cyclase-C agonist developed to treat achalasia, a condition involving the failure of the lower esophageal sphincter to relax. This category provides comprehensive analytical… Read more
![Chemical structure of (4R,5R)-3,3-Dibutyl-5-(4-((4-(chloromethyl)benzyl)oxy)phenyl)-7-(dimethylamino)-4-hydroxy-2,3,4,5-tetrahydrobenzo[b]thiepine 1,1-dioxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F289038-78-4-4R5R-33-Dibutyl-5-4-4-chloromethylbenzyloxyphenyl-7-dimethylamino-4-hydroxy-2345-tetrahydrobenzobthiepine-11-dioxide.png&w=3840&q=75)
![Chemical structure of (4R,5R)-3,3-Dibutyl-7-(dimethylamino)-4-hydroxy-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydrobenzo[b]thiepine 1,1-dioxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F228113-65-3-4R5R-33-Dibutyl-7-dimethylamino-4-hydroxy-5-4-hydroxyphenyl-2345-tetrahydrobenzobthiepine-11-dioxide.png&w=3840&q=75)
![Chemical structure of (4R,5R)-3,3-Dibutyl-7-(dimethylamino)-4-hydroxy-5-(4-methoxyphenyl)-2,3,4,5-tetrahydrobenzo[b]thiepine 1,1-dioxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F228113-64-2-4R5R-33-Dibutyl-7-dimethylamino-4-hydroxy-5-4-methoxyphenyl-2345-tetrahydrobenzobthiepine-11-dioxide.png&w=3840&q=75)
![Chemical structure of 1,4-Diazabicyclo[2.2.2]Octane](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F280-57-9-14-Diazabicyclo2.2.2Octane.png&w=3840&q=75)
![Chemical structure of 1-(4-((4-((4S,5S)-3,3-Dibutyl-7-(dimethylamino)-4-hydroxy-1,1-dioxido-2,3,4,5-tetrahydrobenzo[b]thiepin-5-yl)phenoxy)methyl)benzyl)-1,4-diazabicyclo[2.2.2]octan-1-ium Chloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F228113-67-5-1-4-4-4S5S-33-Dibutyl-7-dimethylamino-4-hydroxy-11-dioxido-2345-tetrahydrobenzobthiepin-5-ylphenoxymethylbenzyl-14-diazabicyclo2.2.2octan-.png&w=3840&q=75)




Lopixibat is a selective guanylate cyclase-C agonist developed to treat achalasia, a condition involving the failure of the lower esophageal sphincter to relax. This category provides comprehensive analytical support for laboratories working with this small molecule, offering a range of high-quality reference standards, metabolites, and impurities. Researchers utilize these materials for impurity profiling, method development, and rigorous quality control testing of the active pharmaceutical ingredient. The selection includes specific synthesis-related compounds, such as the chiral ligand 1,4-diazabicyclo[2.2.2]octane, alongside structurally related degradation products and process-related impurities. Furthermore, stable isotope-labelled compounds, such as deuterated variants, are available to serve as internal standards in mass spectrometry, facilitating precise quantification and validating analytical procedures during drug manufacturing and compliance monitoring.